Global Alzheimer’s Disease Diagnostic Market Research Report 2025(Status and Outlook)

March 2025 | 170 pages | ID: GCE28BE2DB3CEN
Bosson Research

Abstracts

Report Overview

The diagnosis of alzheimer's disease is divided into three steps. The first step is to determine whether it is alzheimer's disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or medial temporal lobe volume atrophy, and the apolipoprotein E4 allele.The third step is to determine the extent of the disease, which can be determined by a simple mental state examination or the patient's response.

This report provides a deep insight into the global Alzheimer’s Disease Diagnostic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Alzheimer’s Disease Diagnostic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Alzheimer’s Disease Diagnostic market in any manner.

Global Alzheimer’s Disease Diagnostic Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eli Lilly and Company

Novartis

Merck

F. Hoffmann-La Roche

Pfizer

TauRx

Alector

Accera

Treventis Corporation

Neuro-Bio

Cognition Therapeutics

Market Segmentation (by Type)

Nervous System Examination

Genetic Testing

Minor Mental State Examination (Mmse)

Brain Imaging

Market Segmentation (by Application)

Early-Onset Alzheimer's Disease

Familial Alzheimer's Disease

Late-Onset Alzheimer's Disease

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Alzheimer’s Disease Diagnostic Market
• Overview of the regional outlook of the Alzheimer’s Disease Diagnostic Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Alzheimer’s Disease Diagnostic Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Alzheimer’s Disease Diagnostic
1.2 Key Market Segments
  1.2.1 Alzheimer’s Disease Diagnostic Segment by Type
  1.2.2 Alzheimer’s Disease Diagnostic Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Alzheimer’s Disease Diagnostic Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Alzheimer’s Disease Diagnostic Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Alzheimer’s Disease Diagnostic Product Life Cycle
3.3 Global Alzheimer’s Disease Diagnostic Sales by Manufacturers (2020-2025)
3.4 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Manufacturers (2020-2025)
3.5 Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Alzheimer’s Disease Diagnostic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Alzheimer’s Disease Diagnostic Manufacturing Sites, Area Served, Product Type
3.8 Alzheimer’s Disease Diagnostic Market Competitive Situation and Trends
  3.8.1 Alzheimer’s Disease Diagnostic Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Alzheimer’s Disease Diagnostic Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 ALZHEIMER’S DISEASE DIAGNOSTIC INDUSTRY CHAIN ANALYSIS

4.1 Alzheimer’s Disease Diagnostic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ALZHEIMER’S DISEASE DIAGNOSTIC MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Alzheimer’s Disease Diagnostic Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Alzheimer’s Disease Diagnostic Market
5.7 ESG Ratings of Leading Companies

6 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Alzheimer’s Disease Diagnostic Sales Market Share by Type (2020-2025)
6.3 Global Alzheimer’s Disease Diagnostic Market Size Market Share by Type (2020-2025)
6.4 Global Alzheimer’s Disease Diagnostic Price by Type (2020-2025)

7 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Alzheimer’s Disease Diagnostic Market Sales by Application (2020-2025)
7.3 Global Alzheimer’s Disease Diagnostic Market Size (M USD) by Application (2020-2025)
7.4 Global Alzheimer’s Disease Diagnostic Sales Growth Rate by Application (2020-2025)

8 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET SALES BY REGION

8.1 Global Alzheimer’s Disease Diagnostic Sales by Region
  8.1.1 Global Alzheimer’s Disease Diagnostic Sales by Region
  8.1.2 Global Alzheimer’s Disease Diagnostic Sales Market Share by Region
8.2 Global Alzheimer’s Disease Diagnostic Market Size by Region
  8.2.1 Global Alzheimer’s Disease Diagnostic Market Size by Region
  8.2.2 Global Alzheimer’s Disease Diagnostic Market Size Market Share by Region
8.3 North America
  8.3.1 North America Alzheimer’s Disease Diagnostic Sales by Country
  8.3.2 North America Alzheimer’s Disease Diagnostic Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Alzheimer’s Disease Diagnostic Sales by Country
  8.4.2 Europe Alzheimer’s Disease Diagnostic Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Alzheimer’s Disease Diagnostic Sales by Region
  8.5.2 Asia Pacific Alzheimer’s Disease Diagnostic Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Alzheimer’s Disease Diagnostic Sales by Country
  8.6.2 South America Alzheimer’s Disease Diagnostic Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Alzheimer’s Disease Diagnostic Sales by Region
  8.7.2 Middle East and Africa Alzheimer’s Disease Diagnostic Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET PRODUCTION BY REGION

9.1 Global Production of Alzheimer’s Disease Diagnostic by Region(2020-2025)
9.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Region (2020-2025)
9.3 Global Alzheimer’s Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Alzheimer’s Disease Diagnostic Production
  9.4.1 North America Alzheimer’s Disease Diagnostic Production Growth Rate (2020-2025)
  9.4.2 North America Alzheimer’s Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Alzheimer’s Disease Diagnostic Production
  9.5.1 Europe Alzheimer’s Disease Diagnostic Production Growth Rate (2020-2025)
  9.5.2 Europe Alzheimer’s Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Alzheimer’s Disease Diagnostic Production (2020-2025)
  9.6.1 Japan Alzheimer’s Disease Diagnostic Production Growth Rate (2020-2025)
  9.6.2 Japan Alzheimer’s Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Alzheimer’s Disease Diagnostic Production (2020-2025)
  9.7.1 China Alzheimer’s Disease Diagnostic Production Growth Rate (2020-2025)
  9.7.2 China Alzheimer’s Disease Diagnostic Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Eli Lilly and Company
  10.1.1 Eli Lilly and Company Basic Information
  10.1.2 Eli Lilly and Company Alzheimer’s Disease Diagnostic Product Overview
  10.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Product Market Performance
  10.1.4 Eli Lilly and Company Business Overview
  10.1.5 Eli Lilly and Company SWOT Analysis
  10.1.6 Eli Lilly and Company Recent Developments
10.2 Novartis
  10.2.1 Novartis Basic Information
  10.2.2 Novartis Alzheimer’s Disease Diagnostic Product Overview
  10.2.3 Novartis Alzheimer’s Disease Diagnostic Product Market Performance
  10.2.4 Novartis Business Overview
  10.2.5 Novartis SWOT Analysis
  10.2.6 Novartis Recent Developments
10.3 Merck
  10.3.1 Merck Basic Information
  10.3.2 Merck Alzheimer’s Disease Diagnostic Product Overview
  10.3.3 Merck Alzheimer’s Disease Diagnostic Product Market Performance
  10.3.4 Merck Business Overview
  10.3.5 Merck SWOT Analysis
  10.3.6 Merck Recent Developments
10.4 F. Hoffmann-La Roche
  10.4.1 F. Hoffmann-La Roche Basic Information
  10.4.2 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product Overview
  10.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product Market Performance
  10.4.4 F. Hoffmann-La Roche Business Overview
  10.4.5 F. Hoffmann-La Roche Recent Developments
10.5 Pfizer
  10.5.1 Pfizer Basic Information
  10.5.2 Pfizer Alzheimer’s Disease Diagnostic Product Overview
  10.5.3 Pfizer Alzheimer’s Disease Diagnostic Product Market Performance
  10.5.4 Pfizer Business Overview
  10.5.5 Pfizer Recent Developments
10.6 TauRx
  10.6.1 TauRx Basic Information
  10.6.2 TauRx Alzheimer’s Disease Diagnostic Product Overview
  10.6.3 TauRx Alzheimer’s Disease Diagnostic Product Market Performance
  10.6.4 TauRx Business Overview
  10.6.5 TauRx Recent Developments
10.7 Alector
  10.7.1 Alector Basic Information
  10.7.2 Alector Alzheimer’s Disease Diagnostic Product Overview
  10.7.3 Alector Alzheimer’s Disease Diagnostic Product Market Performance
  10.7.4 Alector Business Overview
  10.7.5 Alector Recent Developments
10.8 Accera
  10.8.1 Accera Basic Information
  10.8.2 Accera Alzheimer’s Disease Diagnostic Product Overview
  10.8.3 Accera Alzheimer’s Disease Diagnostic Product Market Performance
  10.8.4 Accera Business Overview
  10.8.5 Accera Recent Developments
10.9 Treventis Corporation
  10.9.1 Treventis Corporation Basic Information
  10.9.2 Treventis Corporation Alzheimer’s Disease Diagnostic Product Overview
  10.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Product Market Performance
  10.9.4 Treventis Corporation Business Overview
  10.9.5 Treventis Corporation Recent Developments
10.10 Neuro-Bio
  10.10.1 Neuro-Bio Basic Information
  10.10.2 Neuro-Bio Alzheimer’s Disease Diagnostic Product Overview
  10.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Product Market Performance
  10.10.4 Neuro-Bio Business Overview
  10.10.5 Neuro-Bio Recent Developments
10.11 Cognition Therapeutics
  10.11.1 Cognition Therapeutics Basic Information
  10.11.2 Cognition Therapeutics Alzheimer’s Disease Diagnostic Product Overview
  10.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Product Market Performance
  10.11.4 Cognition Therapeutics Business Overview
  10.11.5 Cognition Therapeutics Recent Developments

11 ALZHEIMER’S DISEASE DIAGNOSTIC MARKET FORECAST BY REGION

11.1 Global Alzheimer’s Disease Diagnostic Market Size Forecast
11.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Alzheimer’s Disease Diagnostic Market Size Forecast by Country
  11.2.3 Asia Pacific Alzheimer’s Disease Diagnostic Market Size Forecast by Region
  11.2.4 South America Alzheimer’s Disease Diagnostic Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Alzheimer’s Disease Diagnostic by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Alzheimer’s Disease Diagnostic Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Alzheimer’s Disease Diagnostic by Type (2026-2033)
  12.1.2 Global Alzheimer’s Disease Diagnostic Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Alzheimer’s Disease Diagnostic by Type (2026-2033)
12.2 Global Alzheimer’s Disease Diagnostic Market Forecast by Application (2026-2033)
  12.2.1 Global Alzheimer’s Disease Diagnostic Sales (K Units) Forecast by Application
  12.2.2 Global Alzheimer’s Disease Diagnostic Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Alzheimer’s Disease Diagnostic Market Size Comparison by Region (M USD)
Table 5. Global Alzheimer’s Disease Diagnostic Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Alzheimer’s Disease Diagnostic Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Alzheimer’s Disease Diagnostic Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Alzheimer’s Disease Diagnostic Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2024)
Table 10. Global Market Alzheimer’s Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Alzheimer’s Disease Diagnostic Manufacturing Sites and Area Served
Table 12. Manufacturers Alzheimer’s Disease Diagnostic Product Type
Table 13. Global Alzheimer’s Disease Diagnostic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Alzheimer’s Disease Diagnostic Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Alzheimer’s Disease Diagnostic Sales by Type (K Units)
Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (M USD)
Table 26. Global Alzheimer’s Disease Diagnostic Sales (K Units) by Type (2020-2025)
Table 27. Global Alzheimer’s Disease Diagnostic Sales Market Share by Type (2020-2025)
Table 28. Global Alzheimer’s Disease Diagnostic Market Size (M USD) by Type (2020-2025)
Table 29. Global Alzheimer’s Disease Diagnostic Market Size Share by Type (2020-2025)
Table 30. Global Alzheimer’s Disease Diagnostic Price (USD/Unit) by Type (2020-2025)
Table 31. Global Alzheimer’s Disease Diagnostic Sales (K Units) by Application
Table 32. Global Alzheimer’s Disease Diagnostic Market Size by Application
Table 33. Global Alzheimer’s Disease Diagnostic Sales by Application (2020-2025) & (K Units)
Table 34. Global Alzheimer’s Disease Diagnostic Sales Market Share by Application (2020-2025)
Table 35. Global Alzheimer’s Disease Diagnostic Market Size by Application (2020-2025) & (M USD)
Table 36. Global Alzheimer’s Disease Diagnostic Market Share by Application (2020-2025)
Table 37. Global Alzheimer’s Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Table 38. Global Alzheimer’s Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 39. Global Alzheimer’s Disease Diagnostic Sales Market Share by Region (2020-2025)
Table 40. Global Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 41. Global Alzheimer’s Disease Diagnostic Market Size Market Share by Region (2020-2025)
Table 42. North America Alzheimer’s Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 43. North America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Alzheimer’s Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 45. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Alzheimer’s Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 48. South America Alzheimer’s Disease Diagnostic Sales by Country (2020-2025) & (K Units)
Table 49. South America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Alzheimer’s Disease Diagnostic Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (M USD)
Table 52. Global Alzheimer’s Disease Diagnostic Production (K Units) by Region(2020-2025)
Table 53. Global Alzheimer’s Disease Diagnostic Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Region (2020-2025)
Table 55. Global Alzheimer’s Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Alzheimer’s Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Alzheimer’s Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Alzheimer’s Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Alzheimer’s Disease Diagnostic Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Eli Lilly and Company Basic Information
Table 61. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product Overview
Table 62. Eli Lilly and Company Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company SWOT Analysis
Table 65. Eli Lilly and Company Recent Developments
Table 66. Novartis Basic Information
Table 67. Novartis Alzheimer’s Disease Diagnostic Product Overview
Table 68. Novartis Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Novartis Business Overview
Table 70. Novartis SWOT Analysis
Table 71. Novartis Recent Developments
Table 72. Merck Basic Information
Table 73. Merck Alzheimer’s Disease Diagnostic Product Overview
Table 74. Merck Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Merck Business Overview
Table 76. Merck SWOT Analysis
Table 77. Merck Recent Developments
Table 78. F. Hoffmann-La Roche Basic Information
Table 79. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product Overview
Table 80. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. F. Hoffmann-La Roche Business Overview
Table 82. F. Hoffmann-La Roche Recent Developments
Table 83. Pfizer Basic Information
Table 84. Pfizer Alzheimer’s Disease Diagnostic Product Overview
Table 85. Pfizer Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Pfizer Business Overview
Table 87. Pfizer Recent Developments
Table 88. TauRx Basic Information
Table 89. TauRx Alzheimer’s Disease Diagnostic Product Overview
Table 90. TauRx Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. TauRx Business Overview
Table 92. TauRx Recent Developments
Table 93. Alector Basic Information
Table 94. Alector Alzheimer’s Disease Diagnostic Product Overview
Table 95. Alector Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Alector Business Overview
Table 97. Alector Recent Developments
Table 98. Accera Basic Information
Table 99. Accera Alzheimer’s Disease Diagnostic Product Overview
Table 100. Accera Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Accera Business Overview
Table 102. Accera Recent Developments
Table 103. Treventis Corporation Basic Information
Table 104. Treventis Corporation Alzheimer’s Disease Diagnostic Product Overview
Table 105. Treventis Corporation Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Treventis Corporation Business Overview
Table 107. Treventis Corporation Recent Developments
Table 108. Neuro-Bio Basic Information
Table 109. Neuro-Bio Alzheimer’s Disease Diagnostic Product Overview
Table 110. Neuro-Bio Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Neuro-Bio Business Overview
Table 112. Neuro-Bio Recent Developments
Table 113. Cognition Therapeutics Basic Information
Table 114. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product Overview
Table 115. Cognition Therapeutics Alzheimer’s Disease Diagnostic Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Cognition Therapeutics Business Overview
Table 117. Cognition Therapeutics Recent Developments
Table 118. Global Alzheimer’s Disease Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 119. Global Alzheimer’s Disease Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Alzheimer’s Disease Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 121. North America Alzheimer’s Disease Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Alzheimer’s Disease Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 123. Europe Alzheimer’s Disease Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Alzheimer’s Disease Diagnostic Sales Forecast by Region (2026-2033) & (K Units)
Table 125. Asia Pacific Alzheimer’s Disease Diagnostic Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Alzheimer’s Disease Diagnostic Sales Forecast by Country (2026-2033) & (K Units)
Table 127. South America Alzheimer’s Disease Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Alzheimer’s Disease Diagnostic Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Alzheimer’s Disease Diagnostic Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Alzheimer’s Disease Diagnostic Sales Forecast by Type (2026-2033) & (K Units)
Table 131. Global Alzheimer’s Disease Diagnostic Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Alzheimer’s Disease Diagnostic Price Forecast by Type (2026-2033) & (USD/Unit)
Table 133. Global Alzheimer’s Disease Diagnostic Sales (K Units) Forecast by Application (2026-2033)
Table 134. Global Alzheimer’s Disease Diagnostic Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Alzheimer’s Disease Diagnostic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Alzheimer’s Disease Diagnostic Market Size (M USD), 2024-2033
Figure 5. Global Alzheimer’s Disease Diagnostic Market Size (M USD) (2020-2033)
Figure 6. Global Alzheimer’s Disease Diagnostic Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Alzheimer’s Disease Diagnostic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Alzheimer’s Disease Diagnostic Product Life Cycle
Figure 13. Alzheimer’s Disease Diagnostic Sales Share by Manufacturers in 2024
Figure 14. Global Alzheimer’s Disease Diagnostic Revenue Share by Manufacturers in 2024
Figure 15. Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Alzheimer’s Disease Diagnostic Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Alzheimer’s Disease Diagnostic Revenue in 2024
Figure 18. Industry Chain Map of Alzheimer’s Disease Diagnostic
Figure 19. Global Alzheimer’s Disease Diagnostic Market PEST Analysis
Figure 20. Global Alzheimer’s Disease Diagnostic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Alzheimer’s Disease Diagnostic Market Share by Type
Figure 27. Sales Market Share of Alzheimer’s Disease Diagnostic by Type (2020-2025)
Figure 28. Sales Market Share of Alzheimer’s Disease Diagnostic by Type in 2024
Figure 29. Market Size Share of Alzheimer’s Disease Diagnostic by Type (2020-2025)
Figure 30. Market Size Share of Alzheimer’s Disease Diagnostic by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Alzheimer’s Disease Diagnostic Market Share by Application
Figure 33. Global Alzheimer’s Disease Diagnostic Sales Market Share by Application (2020-2025)
Figure 34. Global Alzheimer’s Disease Diagnostic Sales Market Share by Application in 2024
Figure 35. Global Alzheimer’s Disease Diagnostic Market Share by Application (2020-2025)
Figure 36. Global Alzheimer’s Disease Diagnostic Market Share by Application in 2024
Figure 37. Global Alzheimer’s Disease Diagnostic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Alzheimer’s Disease Diagnostic Sales Market Share by Region (2020-2025)
Figure 39. Global Alzheimer’s Disease Diagnostic Market Size Market Share by Region (2020-2025)
Figure 40. North America Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Alzheimer’s Disease Diagnostic Sales Market Share by Country in 2024
Figure 43. North America Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Alzheimer’s Disease Diagnostic Market Size Market Share by Country in 2024
Figure 45. U.S. Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Alzheimer’s Disease Diagnostic Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Alzheimer’s Disease Diagnostic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Alzheimer’s Disease Diagnostic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Alzheimer’s Disease Diagnostic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Alzheimer’s Disease Diagnostic Sales Market Share by Country in 2024
Figure 53. Europe Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Alzheimer’s Disease Diagnostic Market Size Market Share by Country in 2024
Figure 55. Germany Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Alzheimer’s Disease Diagnostic Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Alzheimer’s Disease Diagnostic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Alzheimer’s Disease Diagnostic Market Size Market Share by Region in 2024
Figure 68. China Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Alzheimer’s Disease Diagnostic Sales and Growth Rate (K Units)
Figure 79. South America Alzheimer’s Disease Diagnostic Sales Market Share by Country in 2024
Figure 80. South America Alzheimer’s Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 81. South America Alzheimer’s Disease Diagnostic Market Size Market Share by Country in 2024
Figure 82. Brazil Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Alzheimer’s Disease Diagnostic Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Alzheimer’s Disease Diagnostic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Alzheimer’s Disease Diagnostic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Alzheimer’s Disease Diagnostic Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Alzheimer’s Disease Diagnostic Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Alzheimer’s Disease Diagnostic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Alzheimer’s Disease Diagnostic Production Market Share by Region (2020-2025)
Figure 103. North America Alzheimer’s Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Alzheimer’s Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Alzheimer’s Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 106. China Alzheimer’s Disease Diagnostic Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Alzheimer’s Disease Diagnostic Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Alzheimer’s Disease Diagnostic Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Alzheimer’s Disease Diagnostic Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Alzheimer’s Disease Diagnostic Market Share Forecast by Type (2026-2033)
Figure 111. Global Alzheimer’s Disease Diagnostic Sales Forecast by Application (2026-2033)
Figure 112. Global Alzheimer’s Disease Diagnostic Market Share Forecast by Application (2026-2033)